Endomag Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 135

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 6

Endomag General Information

Description

Developer of a medical technology platform designed to improve the global standard of cancer care. The company's magnetic sensing offers minimally-invasive surgical guidance to ensure cancer can be targeted and removed more accurately through magnetic sensing for tumor identification and detection, thereby enabling physicians to carry out tumor localizations and breast cancer staging with one platform.

Contact Information

Website
www.endomag.com
Formerly Known As
Endomagnetics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 330 Cambridge Science Park
  • Milton Road
  • Cambridge CB4 0WN
  • England, United Kingdom
+44 01223 000000

Endomag Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Endomag Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Secondary Transaction - Private 01-Jun-2021 000.00 Completed Generating Revenue
10. Later Stage VC (Series D) 30-Nov-2020 000.00 000.00 00000 Completed Generating Revenue
9. Later Stage VC (Series C) 23-Jul-2018 000.00 000.00 000.00 Completed Generating Revenue
8. Later Stage VC 28-Feb-2017 00.00 000.00 000.00 Completed Generating Revenue
7. Later Stage VC 19-Nov-2014 00.000 000.00 000.00 Completed Generating Revenue
6. Later Stage VC (Series B) 09-Aug-2013 00.000 00.000 000.00 Completed Generating Revenue
5. Early Stage VC (Series A) 11-Nov-2011 00.000 00.000 00.000 Completed Generating Revenue
4. Early Stage VC 09-Sep-2010 00000 00.000 00.000 Completed Generating Revenue
3. Seed Round 01-Aug-2009 $578K $578K 00.000 Completed Generating Revenue
2. Grant 01-Apr-2009 $569K Completed Generating Revenue
To view Endomag’s complete valuation and funding history, request access »

Endomag Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
C2 Preferred 000,000 00.000000 00.00 00.00 00.00 0.000
C1 Preferred 0,000,000 00.000000 00.00 00.00 00.00 00.000
C2 Preferred 0,000,000 00.000000 00.00 00.00 00.00 00.000
C1 Preferred 0,000,000 00.000000 00.00 00.00 00.00 0.000
Preferred B 0,000,000 00.000000 00.00 00.00 00.00 00.000
Ordinary 00,000 00.000000 00.00 00.00 00.00 0.000
Ordinary 000,000 00.000000 00.00 00.00 00.00 0.000
Preference 000,000 00.000000 00.00 00.00 00.00 0.000
Preference 1,397,000 $0.001320 $1.32 $1.32 $1.32 7.48%
Preference 160,400 $0.001320 $0.83 $0.83 $0.83 0.86%
To view Endomag’s complete cap table history, request access »

Endomag Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a medical technology platform designed to improve the global standard of cancer care. The company's magneti
Diagnostic Equipment
Cambridge, United Kingdom
135 As of 2023
000.00
00000000000 000.00

000000

r incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nos
0000000000 000000000
Rehovot, Israel
00 As of 0000
00000
00000000000 00000

000000

olore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident,
0000000000 000000000
Dallas, TX
00 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Endomag Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ClearCut Medical Venture Capital-Backed Rehovot, Israel 00 00000 00000000000 00000
Perimeter Medical Imaging Formerly VC-backed Dallas, TX 00 000.00 000000000 000.00
Lumicell Venture Capital-Backed Newton, MA 00 00000 00000000000 00000
Avelas Biosciences Venture Capital-Backed San Diego, CA 00 000.00 00000000000 000.00
Novian Health Venture Capital-Backed Chicago, IL 00 000.00 0000000000 0 000.00
You’re viewing 5 of 14 competitors. Get the full list »

Endomag Patents

Endomag Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202316925-D0 Improvements in and relating to the manufacture of handheld jointed instruments Pending 03-Nov-2023
GB-202204999-D0 Improvements in or relating to susceptibility probes for detecing surgical markers Pending 05-Apr-2022 00000000000
GB-202204998-D0 Improvements in or relating to susceptibility probes for detecting surgical markers Pending 05-Apr-2022 00000000000
US-20230346251-A1 Systems and methods of managing erroneous signals in marker-based devices Pending 05-Apr-2022 000000000
GB-2617357-A Improvements in or relating to susceptibility probes for detecting surgical markers Pending 05-Apr-2022 G01R33/0017
To view Endomag’s complete patent history, request access »

Endomag Executive Team (10)

Name Title Board Seat Contact Info
Eric Mayes Ph.D Chief Executive Officer & Board Member
Andrew Shawcross Ph.D Chief Operating Officer
Quentin Harmer Ph.D Chief Technology Officer
Mathew Stephens Chief Marketing Officer
Rob Hincks Finance Director
You’re viewing 5 of 10 executive team members. Get the full list »

Endomag Board Members (8)

Name Representing Role Since
David Cummings Molten Ventures Board Member 000 0000
Eric Mayes Ph.D Endomag Chief Executive Officer & Board Member 000 0000
John Brimacombe Self Board Member 000 0000
John Gonzalez-Carvajal Self Chairman 000 0000
Peter Keen Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Endomag Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Endomag Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Molten Ventures Venture Capital Minority 000 0000 000000 0
New Wave Ventures Venture Capital Minority 000 0000 000000 0
Sarum Partners Limited Partner Minority 000 0000 000000 0
Sussex Place Ventures Venture Capital Minority 000 0000 000000 0
UCL Business University Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Endomag Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Actium Biosystem 24-Jun-2014 0000000000 Laboratory Services (Healthcare) 0000 0000
To view Endomag’s complete acquisitions history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »